FogPharma clears $145M series E thanks to Alexis Borisy, ex-J&J CEO Alex Gorsky

Johnson & Johnson’s former pharma R&D chief, now the CEO of FogPharma, has brought on former J&J CEO Alex Gorsky as an investor in the company’s $145 million series E. Gorsky joins a syndicate of heavyweights like RA Capital and General Catalyst who became first-time Fog investors.